Curaleaf Increases Acquisition Offer for Aurora Cannabis to Expand Global Presence

Curaleaf Enhances Offer to Acquire Aurora Cannabis

Curaleaf Holdings, Inc., a recognized leader in both consumer and medical cannabis, has raised its acquisition offer for Aurora Cannabis Inc. The revised proposal signifies a significant 25% increase, offering Aurora shareholders a total of $5.00 per share. This adjustment not only reflects Curaleaf's strategic ambitions but also underscores its commitment to creating a leading global cannabis platform.

The Enhanced Offer Explained

Under the new terms of the Enhanced Offer, Aurora's shareholders would benefit from a composition that includes both cash and stock options. Each Aurora share would provide $1.00 in cash along with approximately 0.4013 Curaleaf shares. Notably, the cash component represents 20% of the total consideration mix, with a marked increase of 33% from the previous offer.

Curaleaf’s increased offer is designed to appeal to Aurora’s shareholders while maintaining an attractive premium. With a total implied consideration that includes an 86% premium over Aurora's unaffected share price, Curaleaf aims to position the acquisition as mutually beneficial for both parties.

Commitment to Shareholder Engagement

Boris Jordan, the Chairman and CEO of Curaleaf, expressed strong confidence in the strategic rationale behind this deal. He noted ongoing discussions with a substantial portion of Aurora’s shareholder base indicating support for the transaction. Despite facing challenges accessing necessary due diligence information from Aurora, Curaleaf remains determined to engage in thorough discussions. Jordan remarked, “This increased offer reflects careful consideration and shareholder input, demonstrating our continued commitment to reaching a successful outcome.”

A Vision for a Unified Future

Combining Curaleaf and Aurora would create a global leader in the cannabis sector, equipped with operations in 17 countries and generating over $1.5 billion in revenue. The synergy from this merger is expected to cut costs by at least $40 million annually. Aurora shareholders stand to gain both from their existing operations and the potential upside of joining Curaleaf's robust market presence.

Curaleaf’s acquisition strategy aims not only to maintain Aurora’s established international business but also to enhance shareholder value through an expanded U.S. market reach and growing regulatory advantages.

Upcoming Procedures

Curaleaf will file a Notice of Variation and Change to streamline this Enhanced Offer with relevant regulatory authorities. This release is set to include financial disclosures suggested by Aurora, showcasing Curaleaf’s dedication to transparency. The company will also extend the expiration date for the offer to ensure ample time for discussions and considerations by Aurora shareholders.

As Curaleaf continues to innovate and lead within the cannabis industry, this strategic acquisition could reshape the landscape, fostering growth and equipping shareholders with new opportunities for engagement in this dynamic sector.

For further information, Aurora shareholders can visit grow.curaleaf.com, or access regulatory filings available on SEDAR and EDGAR. This evolution in the cannabis market signifies not only a strategic acquisition but an opportunity for investors to participate in an evolving global cannabis economy.

Conclusion

In conclusion, Curaleaf's enhanced acquisition offer for Aurora Cannabis represents a significant step toward creating a robust and diversified global cannabis platform. As companies in this sector strive for growth and efficiency, the implications of such mergers will be vital for the future landscape of cannabis investment and ownership.